Results 161 to 170 of about 12,309,063 (288)

Quantifying the Tolerability of Antipsychotic Treatment-Related Side Effects in Schizophrenia: A Survey Study of Patients and Caregiver Proxies

Patient Preference and Adherence
Melissa Culhane Maravic,1 Kelly Birch,1 Anh Thy H Nguyen,1 Alicia Subasinghe,2 Elizabeth Stafford,3 Christopher Zacker2 1Precision AQ, New York, NY, USA; 2Cerevel Therapeutics, Cambridge, MA, USA; 3National Alliance on Mental Illness, Arlington, VA ...
Maravic MC, Birch K, Nguyen ATH, Subasinghe A, Stafford E, Zacker C   +5 more
doaj  

MetaboSERV-a platform for selecting, exchanging, and visualizing metabolomics data with controlled data access. [PDF]

Gigascience
Tucholski T, Maennel A, Njipouombe Nsangou YA, Schuchardt S, Gruber M, Kellermeier F, Dettmer K, Oefner PJ, Gronwald W, Altenbuchinger M, Dönitz J, Zacharias HU.   +11 more
europepmc   +1 more source

Patent data access control and protection using blockchain technology. [PDF]

Sci Rep, 2022
Li H, Li M.
europepmc   +1 more source

Data standards for access to and utilization of PGR [PDF]

, 2015
Alercia, A., Mackay, M.
core  

Satellites: Make data freely accessible [PDF]

Nature, 2013
Turner, W, Buchanan, G, Rondinini, C, Dwyer, J, Herold, M, Pin Koh, L, Leidner, A, Leimgruber, P, Mora, B, Pettorelli, N, Szantoi, Z, Taubenböck, Hannes, Wegmann, Martin, Wikelski, M   +13 more
openaire   +3 more sources

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Data access arrangements in genomic research consortia. [PDF]

Sci Rep
Nicol D, Nielsen J, Archer M.
europepmc   +1 more source

Leveraging Algorithms to Improve Decision-Making Workflows for Genomic Data Access and Management. [PDF]

Biopreserv Biobank, 2022
Rahimzadeh V, Lawson J, Rushton G, Dove ES.   +3 more
europepmc   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

Molecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller, Susanne Ebner, Carmen Haselrieder, Julia K. Günther, Astrid Drasche, Sophie Strich, Chiara Volani, Andrea Medici, Aleksandar Nikolajevic, Alex Deltedesco, Johannes E. Sigmund, Michael J. Blumer, Martin Hermann, Johanna Vanacker, Gerald Brandacher, Eduard Stefan, Omar Torres‐Quesada, Jakob Troppmair   +17 more
wiley   +1 more source

pyBioPortal: a Python package for simplifying cBioPortal data access in cancer research. [PDF]

JAMIA Open
Valerio M, Inno A, Gori S.
europepmc   +1 more source